T1	p 251 345	outpatients affected by generalized anxiety disorders for at least 1 month , was carried out .
T2	p 352 358	1-week
T3	p 374 376	47
T4	p 888 944	Seventy-eight patients completed the first period and 75
T5	p 961 962	.
T6	p 1485 1493	patients
T7	p 1500 1517	second period ) .
T8	i 19 28	ketazolam
T9	i 59 77	placebo-controlled
T10	i 159 203	of ketazolam ( 15 and 30 mg ) with placebo ,
T11	i 235 242	evening
T12	i 405 417	ketazolam 15
T13	i 433 440	placebo
T14	i 1148 1155	placebo
T15	i 1565 1572	placebo
T16	o 545 590	total Hamilton Anxiety Rating Scale ( HAM-A )
T17	o 768 775	Anxiety
T18	o 823 834	HAM-A scale
T19	o 1002 1015	of responders
T20	o 1179 1184	HAM-A
T21	o 1400 1405	scale
T22	o 1518 1530	Tolerability
T23	o 1626 1636	headache .